7.26 Thyroid 2 Flashcards
(39 cards)
mechanism of goiter
- iodine deficiency
- impaired thyroid hormone synthesis
- compensatory increase TSH
- follicle cell hypertrophy and hyperplasia
- increase colloid
- enlarged gland
euthyroid (started out hypo) patient with enlarged gland and no nodules, maybe some visual changes
- diagnosis
- labs
diffuse nontoxic goiter
normal T3, T4, TSH normal or increased
patient from himalayas with large goiter
- type of goiter
- causes
endemic goiter
- deficient dietary iodine
- goitrogens (foods that inhibit thyroid hormone synthesis such as cabbage and sweet potato)
young female with goiter
- type of goiter
sporadic goiter
multinodular goiter caused by
recurrent hyperplasia and involution
morphologic phases of goiters
hyperplastic
- mild enlargement
- small follicles
- few colloid
colloid involution
- if iodine increases or demand for thyroid hormone decreases
- enlarged
- follicles large with flat epithelium
- colloid abundant
symptoms of goiter compression
airway obstruction
dysphagia
SVC syndrome
hyperactive nodule (releases thyroid) + goiter
- diagnosis
Plummer syndrome / toxic multinodular goiter
ways to rule out thyroid malignancy
FNA
possible resection
young male patient with one nodule more likely to be benign or malignant
malignant
functional “hot” nodules that take up radioactive iodine more likely to be benign or malignant
benign
solitary encapsulated mass without capsular or vascular invasion is
follicular adenoma
mass without capsule is
goiter
mass with capsular or vascular invasion
carcinoma
uniform, monomorphic cells that contain colloid
follicular adenoma
cells with abundant eosinophilic cytoplasm and uniform cells
Hurthle cell adenoma (a type of follicular adenoma)
most common thyroid carcinoma
papillary carcinoma
pathogenesis of thyroid carcinoma
- radiation 0-20 yo (acne, nuclear)
- deficient iodine (follicular carcinoma)
Orphan Annie eyes
papillary thyroid carcinoma
nuclear grooves
papillary thyroid carcinoma
intranuclear inclusions
papillary thyroid carcinoma
psammoma bodies
papillary thyroid carcinoma
activated MAP kinase pathway
papillary thyroid carcinoma
genetic mutations of papillary thyroid carcinoma
rearranged RET genes
rearranged NTKR (neurotrophic tyrosine kinase receptor 1)
point mutation in BRAF